Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis
- 23 August 2002
- journal article
- review article
- Published by Wiley in Muscle & Nerve
- Vol. 26 (4) , 438-458
- https://doi.org/10.1002/mus.10186
Abstract
Excitotoxicity may play a role in certain disorders of the motor system thought to be caused by environmentally acquired toxins, including lathyrism and domoic acid poisoning. Motor neurons appear to be particularly susceptible to toxicity mediated via α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA)–kainate receptors. There is a body of evidence implicating glutamatergic toxicity as a contributory factor in the selective neuronal injury occurring in amyotrophic lateral sclerosis (ALS). Interference with glutamate‐mediated toxicity is so far the only neuroprotective therapeutic strategy that has shown benefit in terms of slowing disease progression in ALS patients. Biochemical studies have shown decreased glutamate levels in central nervous system (CNS) tissue and increased levels in the cerebrospinal fluid (CSF) of ALS patients. CSF from ALS patients is toxic to neurons in culture, apparently via a mechanism involving AMPA receptor activation. There is evidence for altered expression and function of glial glutamate transporters in ALS, particularly excitatory amino acid transporter 2 (EAAT2). Abnormal splice variants of EAAT2 have been detected in human CNS. Mitochondrial dysfunction may contribute to excitotoxicity in ALS. Induction of neuronal nitric oxide synthase and cyclooxygenase 2 in ALS may also lead to significant interactions with regulation of the glutamate transmitter system. Certain features of motor neurons may predispose them to the neurodegenerative process in ALS, such as the cell size, mitochondrial activity, neurofilament content, and relative lack of certain calcium‐binding proteins and molecular chaperones. Motor neurons appear vulnerable to toxicity mediated by calcium‐permeable AMPA receptors. The relatively low expression of the glutamate receptor 2 (GluR2) AMPA receptor subunit and the high current density caused by the large number and density of cell surface AMPA receptors are potentially important factors that may predispose to such toxicity. © 2002 Wiley Periodicals, Inc. Muscle Nerve 26: 438–458, 2002Keywords
This publication has 202 references indexed in Scilit:
- Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosisAnnals of Neurology, 2000
- AMPA Receptors Unbound: Membrane Cycling and Synaptic PlasticityNeuron, 2000
- Ionotropic and metabotropic glutamate receptors show unique postsynaptic, presynaptic, and glial localizations in the dorsal cochlear nucleusJournal of Comparative Neurology, 1996
- Cloning and expression of the ε4 subunit of the NMDA receptor channelFEBS Letters, 1992
- High‐affinity kainate a domoate receptors in rat brainFEBS Letters, 1992
- Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stressNeuron, 1989
- Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal systemNeuroscience Letters, 1989
- The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosisAnnals of Neurology, 1988
- Anatomical organization of excitatory amino acid receptors and their pathwaysTrends in Neurosciences, 1987
- Patterns of Excitation of Thalamic Neurones by Amino-acids and by AcetylcholineNature, 1968